WithdrawnObservationalLast updated Feb 8, 2016

Intermittent Versus Continuous Infusion Meropenem in Cystic Fibrosis

A Comparison of the Effect of Intermittent and Continuous Infusion of Meropenem on the Prevalence of Nausea in Pediatric Cystic Fibrosis Patients

Overview

ClinicalTrials.gov ID: NCT02048163
Lead Sponsor: Dayton Children's HospitalOTHER
Brief Summary: The purpose of this study is to compare the incidence of nausea and vomiting following short intermittent versus prolonged intermittent infusion of meropenem.
Study Type: Observational

Status

Overall Status: Withdrawn
Start Date: Dec 2013
Primary Completion Date: Aug 2015Actual
Completion Date: Aug 2015Actual

Study Record Dates

First Submitted: Jan 27, 2014
First Submitted that Met QC Criteria: Jan 27, 2014
First Posted: Jan 29, 2014Estimated
Last Update Submitted that Met QC Criteria: Feb 4, 2016
Last Update Posted: Feb 8, 2016Estimated
Last Verified: Jan 2015

NCT01158937Terminated

Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patients

NCT01429259Completed

Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children

NCT01667094Unknown status

A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis

NCT03452839Completed

Bolus Versus Continuous Infusion of Meropenem

NCT04648696Terminated

Safety and Outcomes Associated With Continuous Versus Intermittent Infusion Vancomycin

NCT05102162Terminated

BL Infusion Trial:Beta-lactam Continuous Versus Intermittent Infusion and Associated Bacterial Resistance and Therapy Outcomes in Critically Ill Patients With Severe Pneumonia